Heterologous protection elicited by candidate monomeric recombinant HIV-1 gp120 vaccine in the absence of cross neutralising antibodies in a macaque model.
about
Passive transfer of modest titers of potent and broadly neutralizing anti-HIV monoclonal antibodies block SHIV infection in macaques.Targeted Isolation of Antibodies Directed against Major Sites of SIV Env Vulnerability.HIV vaccine research and discovery in the nonhuman primates model: a unified theory in acquisition prevention and control of SIV infectionVirus-Like-Vaccines against HIV.
P2860
Heterologous protection elicited by candidate monomeric recombinant HIV-1 gp120 vaccine in the absence of cross neutralising antibodies in a macaque model.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Heterologous protection elicit ...... antibodies in a macaque model.
@ast
Heterologous protection elicit ...... antibodies in a macaque model.
@en
type
label
Heterologous protection elicit ...... antibodies in a macaque model.
@ast
Heterologous protection elicit ...... antibodies in a macaque model.
@en
prefLabel
Heterologous protection elicit ...... antibodies in a macaque model.
@ast
Heterologous protection elicit ...... antibodies in a macaque model.
@en
P2093
P2860
P356
P1433
P1476
Heterologous protection elicit ...... antibodies in a macaque model.
@en
P2093
Claire Ham
Deborah Ferguson
E James Stott
Edward T Mee
Gerald Voss
Joanna Hall
Laura Duffy
Leanne Davis
Mark Hassall
P2860
P2888
P356
10.1186/1742-4690-9-56
P577
2012-07-16T00:00:00Z
P5875
P6179
1028220391